Cloud-based regulatory platforms have the potential to substantially transform how regulatory submissions are developed, transmitted, and reviewed across the full life cycle of drug development. The benefits of cloud-based submission and review include accelerating critical therapies to patients in need globally and efficiency gains for both drug developers and regulators. The key challenge is turning the theoretical promise of cloud-based regulatory platforms into reality to further the application of technology in the regulatory processes. In this publication we outline regulatory policy journeys needed to effect the changes in the external environment that would allow for use of a cloud-based technology, discuss the prerequisites to successfully navigate the policy journeys, and elaborate on future possibilities when adoption of cloud-based regulatory technologies is achieved.
CITATION STYLE
Khalil, R., Macdonald, J. C., Gustafson, A., Aljuburi, L., Bisordi, F., & Beakes-Read, G. (2023). Walking the talk in digital transformation of regulatory review. Frontiers in Medicine. Frontiers Media SA. https://doi.org/10.3389/fmed.2023.1233142
Mendeley helps you to discover research relevant for your work.